Hydrosat raises €51M to expand its thermal infrared satellite constellation and AI analytics, aiming to transform climate, agriculture and water risk monitoring.
Author: Elyse Christian
Swiss biotech startup FluoSphera secures €1.23M to expand its female-led, animal-free, human-relevant drug discovery platform and accelerate safer, more predictive therapies.
Biotech startup Nuclera secures an extra $12M in Series C funding to accelerate protein production and compress drug discovery timelines.
Zurich-based Ahead Health secures €5.1M to expand its data-driven preventive healthcare platform and strengthen its footprint across European markets.
Cambridge-based Nuclera is reshaping drug discovery by giving labs rapid, benchtop access to functional proteins through its eProtein Discovery platform.
As flashy apps plateau, the most valuable travel tech in 2026 will live deep in infrastructure, data and connectivity—far from the customer-facing interface.
From Web Summit to Slush, these 30+ European startup events in 2026 offer founders unmatched networking, fundraising and learning opportunities across the continent.
Finnish startup Avenue Biosciences secures €4.8M to help drugmakers manufacture complex proteins more reliably, targeting faster, cheaper and more scalable biopharmaceutical production.
Swiss startup FluoSphera secures CHF 1.15M seed funding to scale 3D human organ models designed to predict drug toxicity earlier and cut costly clinical trial failures.
French MedTech FineHeart raises €83M in private capital and EU grants to accelerate its implantable cardiac device for patients with advanced heart failure.